Entrada Therapeutics Inc had a revenue of 1.30M in the quarter ending Dec 31, 2025, with -19.52%. This bring the company's revenue in the last twelve months to 25.42M, Increased -58.68%. In the fiscal year ending Dec 31, 2025, Entrada Therapeutics Inc had annual revenue of 25.42M with -87.94% growth.